166254-15-5

Upstream product

• 166253-58-3 (E)-3-(5-methyl-2-phenyl-4-oxazolylmethoxy)cinnamaldehyde 
• 166253-56-1 ethyl (E)-3-(5-methyl-2-phenyl-4-oxazolylmethoxy)cinnamate 
• 166253-57-2 (E)-3-[3-(5-Methyl-2-phenyl-oxazol-4-ylmethoxy)-phenyl]-prop-2-en-1-ol 
• 159017-85-3 3-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzaldehyde 
• 166253-59-4 (2E,4E)-5-[3-(5-Methyl-2-phenyl-oxazol-4-ylmethoxy)-phenyl]-penta-2,4-dienenitrile 

Relevant academic research and scientific papers

Novel 5-substituted-1H-tetrazole derivatives as potent glucose and lipid lowering agents.

A series of 5-(4-alkoxyphenylalkyl)-1H-tetrazole derivatives, containing an oxazole-based group at the alkoxy moiety, was prepared and their antidiabetic effects were evaluated in two genetically obese and diabetic animal models, KKAy mice and Wistar fatt

Tetrazole derivatives, their production and use

Novel tetrazole derivatives represented by the formula STR1 wherein n denotes an integer of 1 to 3; A is an optionally substituted heterocyclic residue; Y is a divalent hydrocarbon residue; and X is CH or N, or pharmaceutically acceptable salts thereof ha